{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1570291226794684928.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"NAID","@value":"80015318790"}}],"dc:title":[{"@language":"en","@value":"A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1580291226794684928","@type":"Researcher","foaf:name":[{"@language":"en","@value":"NISHI M"}]}],"publication":{"prism:publicationName":[{"@language":"en","@value":"Biochem. Biophys. Res. Commun."}],"prism:publicationDate":"2002","prism:volume":"293","prism:startingPage":"247","prism:endingPage":"251"},"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390001206299009920","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Signal Transduction Pathway through Activin Receptors as a Therapeutic Target of Musculoskeletal Diseases and Cancer"},{"@value":"Signal transduction pathways through activin receptors as therapeutic targets for musculoskeletal diseases and cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1520290884062738816","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Atelocollagen-mediated systemic administration of myostatin-targeting siRNA improves muscular atrophy in caveolin-3-deficient mice"},{"@language":"ja-Kana","@value":"Atelocollagen mediated systemic administration of myostatin targeting siRNA improves muscular atrophy in caveolin 3 deficient mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572358266543616","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"Myostatin阻害による筋ジストロフィー治療戦略"},{"@language":"ja-Kana","@value":"Myostatin ソガイ ニ ヨル キンジストロフィー チリョウ センリャク"}]},{"@id":"https://cir.nii.ac.jp/crid/1570291225665285120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"筋萎縮をきたす神経・筋難病の新しい治療法の開発"},{"@language":"en","@value":"Development of therapies against neuromuscular diseases causing muscle atrophy"}]}],"dataSourceIdentifier":[{"@type":"CIA","@value":"80015318790"}]}